Exforge HCT 25 mg/1 (Amlodipine Valsartan and Hydrochlorothiazide TABLET, FILM COATED) 25 mg/1

Exforge HCT 25 mg/1 combines amlodipine, valsartan, and hydrochlorothiazide for blood pressure management. This oral tablet helps regulate hypertension with a triple-action formula.

Strength

25 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0078-0562-15)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Exforge HCT 25 mg/1 is used to manage high blood pressure. The combination of amlodipine, valsartan, and hydrochlorothiazide works to relax blood vessels and reduce fluid retention. This medication is often prescribed for individuals who need multiple mechanisms to control hypertension.

Side Effects

Common effects of Exforge HCT 25 mg/1 may include dizziness, fatigue, and swelling in the legs or ankles. Some users also report headaches or stomach discomfort. These effects vary and are not experienced by everyone.

Precautions & Warnings

Exforge HCT 25 mg/1 should be handled with care, especially for those with kidney or liver issues. It is important to follow medical advice regarding diet and other medications. Always store the tablets in a cool, dry place.

Avoid Interactions

Exforge HCT 25 mg/1 may interact with other blood pressure medications, diuretics, and certain pain relievers. Alcohol and some supplements can also affect its efficacy. Consult a healthcare provider before combining with other treatments.

Frequently Asked Questions

Exforge HCT 25 mg/1 is used to manage high blood pressure by combining three active ingredients to regulate blood pressure levels.

Exforge HCT 25 mg/1 is taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include dizziness, fatigue, and swelling in the legs or ankles. Headaches and stomach discomfort are also possible.

Exforge HCT 25 mg/1 may interact with other blood pressure medications and diuretics. Always consult a healthcare provider before combining with other treatments.

Exforge HCT 25 mg/1 should be used with caution in individuals with kidney or liver issues. Always follow medical advice regarding its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.